Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.
paper
Cited
Public
Unavailable
- Authors
- Di Marzo, Vincenzo
- Year
- 2011
- Journal
- Nature neuroscience
- PMID
- 21187849
- DOI
- 10.1038/nn.2720
Studies of the endocannabinoid system in the CNS have been mostly focused on endocannabinoid receptors and inactivating mechanisms. Until recently, very little was known about the role of biosynthetic enzymes in endocannabinoid signaling. New data from the recent development of pharmacological and genetic tools for the study of these enzymes point to their fundamental role in determining where and when endocannabinoids function, and raise the possibility of new intriguing and previously unsuspected concepts in the general strategy of endocannabinoid signaling. However, even with these new tools, the cross-talk between anandamide and 2-arachidonoylglycerol biosynthesis makes it difficult to dissect one from the other, and data will need to be interpreted with this in mind.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Implications of the mitochondrial CB1 receptor in the brain: from mitochondrial dysfunction to neuroprotection. | MartΓnez-Torres AM et al. | β | 2026 | β |
| Prenatal THC exposure and binge-like alcohol drinking in early adolescence: From sex-specific drinking vulnerability to abnormal endocannabinoid-dopamine nexus in the nucleus accumbens. | Castelli V et al. | β | 2026 | β |
| A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use. | Rabin RA et al. | β | 2025 | β |
| Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy. | Montebello G et al. | β | 2025 | β |
| Maternal Immune Activation and the Endocannabinoid System: Focus on Two-Hit Models of Schizophrenia. | Santoni M et al. | β | 2025 | β |
| Optimization of a naphthyl amide class identifies potent and selective reversible monoacylglycerol lipase (MAGL) inhibitors. | Song C et al. | β | 2025 | β |
| Role of Endocannabinoids in Glaucoma: A Review. | Warjri GB et al. | β | 2025 | β |
| Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease. | Thapa D et al. | β | 2025 | β |
| Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders. | Kumar U | β | 2024 | β |
| Design, synthesis and biological evaluation of naphthyl amide derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors. | Yu Q et al. | β | 2024 | β |
| Dorsal prefrontal cortex drives perseverative behavior in mice | Lebedeva A et al. | β | 2024 | β |
| Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring. | Santoni M et al. | β | 2023 | β |
| A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature. | Kemble AM et al. | β | 2022 | β |
| Attenuation of allodynia and microglial reactivity by inhibiting the degradation of 2-arachidonoylglycerol following injury to the trigeminal nerve in mice. | Kamimura R et al. | β | 2022 | β |
| Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling. | Deng H et al. | β | 2022 | β |
| Fatty acid amide hydrolase inhibition and N-arachidonoylethanolamine modulation by isoflavonoids: A novel target for upcoming antidepressants. | Zada W et al. | β | 2022 | β |
| Genetic variation in endocannabinoid signaling is associated with differential network-level functional connectivity in youth. | Sisk LM et al. | β | 2022 | β |
| Roles of the Cannabinoid System in the Basal Ganglia in Parkinson's Disease. | Wang M et al. | β | 2022 | β |
| The Endocannabinoid Analgesic Entourage Effect: Investigations in Cultured DRG Neurons. | Anand U et al. | β | 2022 | β |
| An Autonomous Cannabinoid System in Islets of Langerhans. | Aseer KR et al. | β | 2021 | β |
| Cannabinoids: Revealing their complexity and role in central networks of fear and anxiety. | Murkar A et al. | β | 2021 | β |
| CB<sub>1</sub> antagonism increases excitatory synaptogenesis in a cortical spheroid model of fetal brain development. | Papariello A et al. | β | 2021 | β |
| Discovering the Lost Reward: Critical Locations for Endocannabinoid Modulation of the Cortico-Striatal Loop That Are Implicated in Major Depression. | Goldstein Ferber S et al. | β | 2021 | β |
| Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping. | Goldstein Ferber S et al. | β | 2021 | β |
| InΒ vivo endocannabinoid dynamics at the timescale of physiological and pathological neural activity. | Farrell JS et al. | β | 2021 | β |
| mGluR5-Mediated eCB Signaling in the Nucleus Accumbens Controls Vulnerability to Depressive-Like Behaviors and Pain After Chronic Social Defeat Stress. | Xu X et al. | β | 2021 | β |
| Microglial Cannabinoid Type 1 Receptor Regulates Brain Inflammation in a Sex-Specific Manner. | De Meij J et al. | β | 2021 | β |
| Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome. | Forteza F et al. | β | 2021 | β |
| Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system. | van Esbroeck ACM et al. | β | 2020 | β |
| Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation. | Thapa D et al. | β | 2020 | β |
| Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis. | Johal H et al. | β | 2020 | β |
| Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology. | Tanaka M et al. | β | 2020 | β |
| Endocannabinoid Signaling for GABAergic-Microglia (Mis)Communication in the Brain Aging. | Carrera J et al. | β | 2020 | β |
| Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R). | Fletcher-Jones A et al. | β | 2020 | β |
| The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease. | Han QW et al. | β | 2020 | β |
| Antioxidative and Anti-Inflammatory Properties of Cannabidiol. | Atalay S et al. | β | 2019 | β |
| Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. | Agarwal R et al. | β | 2019 | β |
| Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system. | Wyrofsky RR et al. | β | 2019 | β |
| Identification of Ξ±,Ξ²-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells. | van Esbroeck ACM et al. | β | 2019 | β |
| Interference with the Cannabinoid Receptor CB1R Results in Miswiring of GnRH3 and AgRP1 Axons in Zebrafish Embryos. | Zuccarini G et al. | β | 2019 | β |
| Oleoylethanolamide restores alcohol-induced inhibition of neuronal proliferation and microglial activity in striatum. | Rivera P et al. | β | 2019 | β |
| Cannabinoids during ischemic strokes: friends or foes? | Pires PW | β | 2018 | β |
| Design and Synthesis of Quenched Activity-based Probes for Diacylglycerol Lipase and Ξ±,Ξ²-Hydrolase Domain Containing Protein 6. | van Rooden EJ et al. | β | 2018 | β |
| Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System. | Augustin SM et al. | β | 2018 | β |
| The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine. | Ferreira RCM et al. | β | 2018 | β |
| The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. | Meyer HC et al. | β | 2018 | β |
| A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2. | Lu C et al. | β | 2017 | β |
| CB<sub>1</sub> Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal. | Saravia R et al. | β | 2017 | β |
| Endocannabinoid Turnover. | Fowler CJ et al. | β | 2017 | β |
| FAAH inhibition produces antidepressant-like efforts of mice to acute stress via synaptic long-term depression. | Wang Y et al. | β | 2017 | β |
| Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents. | Duan T et al. | β | 2017 | β |
| Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses. | Wang Y et al. | β | 2017 | β |
| Nongenomic Glucocorticoid Suppression of a Postsynaptic Potassium Current via Emergent Autocrine Endocannabinoid Signaling in Hypothalamic Neuroendocrine Cells following Chronic Dehydration. | Wu N et al. | β | 2017 | β |
| Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence. | Garcia-Marchena N et al. | β | 2017 | β |
| Quantitative profiling of endocannabinoids and related <i>N</i>-acylethanolamines in human CSF using nano LC-MS/MS. | Kantae V et al. | β | 2017 | β |
| The cannabinoid system and pain. | Woodhams SG et al. | β | 2017 | β |
| URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors. | Escamilla-RamΓrez A et al. | β | 2017 | β |
| A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women. | Pastor A et al. | β | 2016 | β |
| Developmental regulation of fear learning and anxiety behavior by endocannabinoids. | Lee TT et al. | β | 2016 | β |
| Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders. | Iannotti FA et al. | β | 2016 | β |
| Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors. | Staiano RI et al. | β | 2016 | β |
| Microglia activation states and cannabinoid system: Therapeutic implications. | Mecha M et al. | β | 2016 | β |
| Oxygenation of Anandamide by Lipoxygenases. | van Zadelhoff G et al. | β | 2016 | β |
| Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats. | Kiritoshi T et al. | β | 2016 | β |
| Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease. | Cairns EA et al. | β | 2016 | β |
| Structure activity relationship studies on chemically non-reactive glycine sulfonamide inhibitors of diacylglycerol lipase. | Chupak LS et al. | β | 2016 | β |
| The Endocannabinoid System as a Therapeutic Target in Glaucoma. | Cairns EA et al. | β | 2016 | β |
| 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons. | Llorente-Berzal A et al. | β | 2015 | β |
| Age-related changes in the endocannabinoid system in the mouse hippocampus. | Piyanova A et al. | β | 2015 | β |
| BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons. | Zhong P et al. | β | 2015 | β |
| Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour. | RodrΓguez-Manzo G et al. | β | 2015 | β |
| Comprehensive Analysis of Structure-Activity Relationships of Ξ±-Ketoheterocycles as sn-1-Diacylglycerol Lipase Ξ± Inhibitors. | Janssen FJ et al. | β | 2015 | β |
| Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease. | Wyrofsky R et al. | β | 2015 | β |
| Elucidating cannabinoid biology in zebrafish (Danio rerio). | Krug RG et al. | β | 2015 | β |
| Endocannabinoids drive the acquisition of an alternative phenotype in microglia. | Mecha M et al. | β | 2015 | β |
| Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. | Bashashati M et al. | β | 2015 | β |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | β | 2015 | β |
| The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract. | Trautmann SM et al. | β | 2015 | β |
| The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease. | Mazier W et al. | β | 2015 | β |
| ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice. | Naydenov AV et al. | β | 2014 | β |
| Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model. | Greco R et al. | β | 2014 | β |
| Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs. | Pastor A et al. | β | 2014 | β |
| CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model. | Ji G et al. | β | 2014 | β |
| Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training. | Bystrowska B et al. | β | 2014 | β |
| Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus. | Yang K et al. | β | 2014 | β |
| Endocannabinoids and energy homeostasis: an update. | Cristino L et al. | β | 2014 | β |
| Endocannabinoids produced upon action potential firing evoke a Cl(-) current via type-2 cannabinoid receptors in the medial prefrontal cortex. | den Boon FS et al. | β | 2014 | β |
| Endocannabinoids, related compounds and their metabolic routes. | Fezza F et al. | β | 2014 | β |
| Miswiring the brain: Ξ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway. | Tortoriello G et al. | β | 2014 | β |
| Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome. | Lysenko LV et al. | β | 2014 | β |
| New horizons on the role of cannabinoid CB1 receptors in palatable food intake, obesity and related dysmetabolism. | Cristino L et al. | β | 2014 | β |
| Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde signalling: evidence for on-demand biosynthesis of 2-arachidonoylglycerol. | Hashimotodani Y et al. | β | 2013 | β |
| Anandamide-derived prostamide F2Ξ± negatively regulates adipogenesis. | Silvestri C et al. | β | 2013 | β |
| Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. | Vincenzi F et al. | β | 2013 | β |
| Depolarization-induced suppression of a glycinergic synapse in the superior olivary complex by endocannabinoids. | Trattner B et al. | β | 2013 | β |
| Developmental pattern of diacylglycerol lipase-Ξ± (DAGLΞ±) immunoreactivity in brain regions important for song learning and control in the zebra finch (Taeniopygia guttata). | Soderstrom K et al. | β | 2013 | β |
| Development of an activity-based probe and in silico design reveal highly selective inhibitors for diacylglycerol lipase-Ξ± in brain. | Baggelaar MP et al. | β | 2013 | β |
| Endocannabinoid signals in the developmental programming of delayed-onset neuropsychiatric and metabolic illnesses. | Keimpema E et al. | β | 2013 | β |
| Endocannabinoid system: potential novel targets for treatment of schizophrenia. | Saito A et al. | β | 2013 | β |
| Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1. | Kiritoshi T et al. | β | 2013 | β |
| Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans. | Fagundo AB et al. | β | 2013 | β |
| Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. | Cristino L et al. | β | 2013 | β |
| Targeted lipidomics in Drosophila melanogaster identifies novel 2-monoacylglycerols and N-acyl amides. | Tortoriello G et al. | β | 2013 | β |
| Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. | Lee TT et al. | β | 2013 | β |
| The combination of oral L-DOPA/rimonabant for effective dyskinesia treatment and cytological preservation in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia. | GutiΓ©rrez-Valdez AL et al. | β | 2013 | β |
| The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy. | Slusar JE et al. | β | 2013 | β |
| Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. | Luchicchi A et al. | β | 2012 | β |
| Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. | CallΓ©n L et al. | β | 2012 | β |
| Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia. | Schmidt W et al. | β | 2012 | β |
| Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures. | Bojnik E et al. | β | 2012 | β |
| DAGLΞ² inhibition perturbs a lipid network involved in macrophage inflammatory responses. | Hsu KL et al. | β | 2012 | β |
| Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. | Alger BE | β | 2012 | β |
| Endocannabinoid signaling and synaptic function. | Castillo PE et al. | β | 2012 | β |
| Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. | den Boon FS et al. | β | 2012 | β |
| Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity. | Butti E et al. | β | 2012 | β |
| The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling. | Reisenberg M et al. | β | 2012 | β |
| The endocannabinoid system in normal and pathological brain ageing. | Bilkei-Gorzo A | β | 2012 | β |
| Vignettes: models in absentia. | Denman RB | β | 2012 | β |
| Why do cannabinoid receptors have more than one endogenous ligand? | Di Marzo V et al. | β | 2012 | β |
| DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis. | Oudin MJ et al. | β | 2011 | β |
| Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. | Wu CS et al. | β | 2011 | β |
| Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. | Yoshino H et al. | β | 2011 | β |
| Supply and demand for endocannabinoids. | Alger BE et al. | β | 2011 | β |
| Target-dependent control of synaptic inhibition by endocannabinoids in the thalamus. | Sun YG et al. | β | 2011 | β |
| Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease. | Basu S et al. | β | 2011 | β |